Tradestie Institutional Equity Comparison Engine

CVM vs ADVM โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ADVM Overall Edge

ADVM Captures Institutional Edge (2โ€“2 Pillars ยท 4โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Adverum Biotechnologies, Inc. Common Stock (ADVM) driven by superior Momentum & Technical, Options & Structure while CVM counters with relative strength in Valuation, Growth & Margin. Fundamentally, CVM trades at 23.0x Forward P/E with 0.0% operating margin (-62.7% YoY revenue) versus ADVM at N/M Forward P/E and 0.0% operating margin (-70.0% YoY). In options structure, CVM sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against ADVM sits in UNCLASSIFIED (10th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner CVM
CVM 23.0x vs ADVM N/M Fwd P/E
Growth & Margin Winner CVM
Op Margin 0.0% vs 0.0% ยท YoY -62.7% vs -70.0%
Momentum & Technical Winner ADVM
1Y -77.5% vs -27.3% ยท 52W Pos 10% vs 55%
Options & Structure Winner ADVM
BREAKDOWN (N/A IV) vs UNCLASSIFIED (10th %ile IV)
CVM NYSE American
Cel-Sci Corporation
Biological Products, (No Disgnostic Substances)
$1.59
+24.22% 1D
Market Cap $20.9M
1M Return -11.17%
1Y Return -77.48%
Forward P/E 23.0x
Unified AI Score
56.6 / 100 HOLD
Tech 60.0 Fund 54.0 Flow 50.0 Mom 60.0
ADVM NASDAQ
Adverum Biotechnologies, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$4.36
+4.06% 1D
Market Cap $91.8M
1M Return +1.87%
1Y Return -27.33%
Forward P/E N/M
Unified AI Score
62.4 / 100 BUY
Tech 60.0 Fund 57.0 Flow 62.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CVM -77.48% ADVM -27.33% Spread: +12.12 pp (ADVM Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CVM TTM Op. Margin: 0.0% ADVM TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CVM vs ADVM. Trailing 12-month operating profitability (CVM 0.0% vs ADVM 0.0%) and valuation multiples (CVM 23.0x vs ADVM N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CVM (4) vs ADVM (4)
Institutional Metric CVM ADVM Criterion Row Winner
Market Capitalization Scale $20.9M $91.8M Larger Scale ADVM
Trailing P/E Ratio Valuation 23.0x N/M Lower Multiple CVM
Forward P/E Ratio Valuation 23.0x N/M Lower Multiple CVM
Revenue Growth (YoY) Growth -62.7% -70.0% Higher Growth CVM
Operating Margin (TTM) Profitability 0.0% 0.0% Higher Margin Tie
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -252.5% -417.8% Higher ROE CVM
52-Week Range Position Momentum 10% ($1โ€“$8) 55% ($2โ€“$6) Stronger Trend ADVM
Beta / 30D Volatility Risk Regime 0.65ฮฒ ยท 120% Vol 1.04ฮฒ ยท 17% Vol Lower Realized Risk ADVM
Unified Institutional Score Composite Signal 56.6 / 100 (HOLD) 62.4 / 100 (BUY) Higher Composite ADVM

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CVM vs ADVM Buy Guide
CVM BREAKDOWN
29d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CVM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ADVM UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 10th %ile
IV Regime Compressed (<25th %ile)
Live ADVM Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CVM nor ADVM registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.